Myanmar

3 Vaccines Approved for Use in Myanmar

Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
4 trials in 1 country
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries
Approval Source: global.chinadaily.com.cn